Search Results

Filter
  • 1-5 of  5 results for ""Cholesterol Ester Transfer Proteins""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

HDL-C levels and cardiovascular disease: more is not always better!

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*pharmacology ; Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*drug therapy

  • Source: Recent patents on cardiovascular drug discovery [Recent Pat Cardiovasc Drug Discov] 2012 Aug; Vol. 7 (2), pp. 121-33.Publisher: Bentham Science Publishers LTD Country of Publication: United Arab Emirates NLM ID: 101263805 Publication Model:

Record details

×
Academic Journal

Current status of CETP inhibitors in the treatment of hyperlipidemia: an update.

  • Authors : Ghosh RK; Department of Pharmacology, Maulana Azad Medical College, New Delhi, India. ; Ghosh SM

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*pharmacology ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors ; Hyperlipidemias/Hyperlipidemias/Hyperlipidemias/*drug therapy

  • Source: Current clinical pharmacology [Curr Clin Pharmacol] 2012 May; Vol. 7 (2), pp. 102-10.Publisher: Bentham Science Publishers Ltd Country of Publication: United Arab Emirates NLM ID: 101273158 Publication Model:

Record details

×
Academic Journal

Anacetrapib: a new weapon against dyslipidemia.

  • Authors : Aperis G; Nephrology Department, General Hospital of Rhodes, Agioi Apostoloi, Greece. ; Paliouras C

Subjects: Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors ; Dyslipidemias/Dyslipidemias/Dyslipidemias/*drug therapy ; Oxazolidinones/Oxazolidinones/Oxazolidinones/*pharmacology

  • Source: Current clinical pharmacology [Curr Clin Pharmacol] 2011 Nov; Vol. 6 (4), pp. 227-35.Publisher: Bentham Science Publishers Ltd Country of Publication: United Arab Emirates NLM ID: 101273158 Publication Model:

Record details

×
Academic Journal

HDL elevation and lipid lowering therapy: current scenario and future perspectives.

  • Authors : Chhabria MT; Department of Pharmaceutical Chemistry and Quality Assurance, L M College of Pharmacy, Navrangpura, Ahmedabad - 380 009, Gujarat, India. ; Suhagia BN

Subjects: Cholesterol, HDL/Cholesterol, HDL/Cholesterol, HDL/*blood ; Dyslipidemias/Dyslipidemias/Dyslipidemias/*prevention & control ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*therapeutic use

  • Source: Recent patents on cardiovascular drug discovery [Recent Pat Cardiovasc Drug Discov] 2007 Nov; Vol. 2 (3), pp. 214-27.Publisher: Bentham Science Publishers LTD Country of Publication: United Arab Emirates NLM ID: 101263805 Publication Model:

Record details

×
Academic Journal

New approaches to atherosclerotic cardiovascular disease. the potentialities of torcetrapib.

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*drug therapy ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors

  • Source: Recent patents on cardiovascular drug discovery [Recent Pat Cardiovasc Drug Discov] 2006 Jan; Vol. 1 (1), pp. 109-14.Publisher: Bentham Science Publishers LTD Country of Publication: United Arab Emirates NLM ID: 101263805 Publication Model:

Record details

×
  • 1-5 of  5 results for ""Cholesterol Ester Transfer Proteins""